Rosales

Glimirosal MV 2.3 (Metformin HCL PR 500 mg & Glimepiride 2 mg & Voglibose 0.3 mg) is a Bilayer Technology Tablets,  ‘Bilayer tablets are the medicines that consist of two same or different drugs combined in a single dose for effective treatment of the disease’ that belongs to a group of drugs called Biguanides and Sulfonylureas and competitive α glucosidase inhibitors (α-GIs).